Questionnaire Administration for Oral Squamous Cell Carcinoma

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
OHSU Knight Cancer Institute, Portland, OR
Oral Squamous Cell Carcinoma+5 More
Questionnaire Administration - Other
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This clinical trial studies the use of "smart" body-weight scales to monitor weight and nutrition among patients with head and neck cancer undergoing radiation therapy. Malnutrition affects 30-50% of patients diagnosed with head and neck cancer, and approximately 30% of patients have malnutrition prior to diagnosis. "Smart" body weight scales can possibly make self-weighing easier, faster, and more accurate through weight recordings through mobile applications available for "smart" scales. This has the potential to maximize nutritional guidance through quick weight updates, possibly delaying or removing the use of patient enteral feeding (tube feeding). By avoiding or minimizing the use of enteral feeding during radiation therapy, the risk of long-term tube dependence and swallowing ability complications may be reduced.

Eligible Conditions

  • Oral Squamous Cell Carcinoma
  • Malignant Neoplasms

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Oral Squamous Cell Carcinoma

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Up to 3 months post-radiation therapy

Month 3
MD Anderson Symptom Inventory for Head and Neck Cancer (MDASI-HN) questionnaire scores
Month 3
Overall pain scores
Weight loss percentage
Up to 8 weeks
Adherence to treatment

Trial Safety

Safety Progress

1 of 3

Other trials for Oral Squamous Cell Carcinoma

Trial Design

2 Treatment Groups

Cohort 2 (no weighing)
1 of 2
Cohort I ('Smart" scale weighing)
1 of 2
Active Control
Experimental Treatment

20 Total Participants · 2 Treatment Groups

Primary Treatment: Questionnaire Administration · No Placebo Group · N/A

Cohort I ('Smart" scale weighing)Experimental Group · 2 Interventions: Questionnaire Administration, Medical Device Qardio® smart scale Usage and Evaluation · Intervention Types: Other, Other
Cohort 2 (no weighing)
Other
ActiveComparator Group · 1 Intervention: Questionnaire Administration · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 3 months post-radiation therapy
Closest Location: OHSU Knight Cancer Institute · Portland, OR
Photo of Portland 1Photo of Portland 2Photo of Portland 3
2003First Recorded Clinical Trial
0 TrialsResearching Oral Squamous Cell Carcinoma
102 CompletedClinical Trials

Who is running the clinical trial?

Cambia Health FoundationUNKNOWN
2 Previous Clinical Trials
173 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
880 Previous Clinical Trials
6,828,309 Total Patients Enrolled
OHSU Knight Cancer InstituteLead Sponsor
206 Previous Clinical Trials
2,090,822 Total Patients Enrolled
Ravi ChandraPrincipal InvestigatorOHSU Knight Cancer Institute

Eligibility Criteria

Age Any Age · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
The ability to properly utilize a \"smart\" body weight scale after appropriate training has been provided
You have squamous cell carcinoma of the head and neck.
You are able to understand the nature and purpose of the study and are willing to sign a written informed consent document.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.